Ausgabe 5/2011
Inhalt (13 Artikel)
Clinical Trials Report: Low-dose Oral Desmopressin for Nocturia
Alana M. Murphy, Howard B. Goldman
Retropubic and Transobturator Slings: Still Useful or Should All Patients Be Treated with Mini-slings?
Michael J. Kennelly, Erinn M. Myers
How Does Sacral Modulation Work Best? Placement and Programming Techniques to Maximize Efficacy
Bastian Amend, Mahmoud Khalil, Thomas M. Kessler, Karl-Dietrich Sievert
Stem Cell Therapy for Incontinence: Where Are We Now? What is the Realistic Potential?
Charuspong Dissaranan, Michelle A. Cruz, Bruna M. Couri, Howard B. Goldman, Margot S. Damaser
Does Estrogen Have Any Real Effect on Voiding Dysfunction in Women?
Michelle E. Koski, Christopher J. Chermansky
Antimuscarinic Drugs: Review of the Cognitive Impact When Used to Treat Overactive Bladder in Elderly Patients
Dustin Pagoria, R. Corey O’Connor, Michael L. Guralnick
The Financial Burden of Stress Urinary Incontinence Among Women in the United States
Erin C. Chong, Aqsa A. Khan, Jennifer T. Anger
Risk Factors for the Development of Stress Urinary Incontinence in Women
Lynn Stothers, Boris Friedman
Epidemiology of Stress Urinary Incontinence in Women
W. Stuart Reynolds, Roger R. Dmochowski, David F. Penson
Voiding Dysfunction in the Female Patient: Is the “Syndrome” Paradigm Valid?
Hari Siva G. R. Tunuguntla, Renuka Tunuguntla, Joseph Barone, Prashanth Kanagarajah, Angelo E. Gousse
Validated Instruments in the Evaluation and Treatment Outcomes of Stress Urinary Incontinence in Women
Gjanjé L. Smith, Kathleen C. Kobashi